Nanostructured cochleates: a multi-layered platform for cellular transportation of therapeutics

References

• Yingchoncharoen P, Kalinowski DS, Richardson DR. Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come. Pharmacol Rev. 2016;68:701–787.
   PubMed Web of Science ®Google Scholar
• Jha S, Dey S, Karki R. Microemulsions - potential carrier for improved drug delivery. Asian J Biomed Pharm Sci. 2011;1:5–9.
   Google Scholar
• Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech. 2015;5:123–127.
   PubMedGoogle Scholar
• Shende P, Gaud R. Validated RP-HPLC analysis of irinotecan HCl in the bulk material and in pharmaceutical formulations. Acta Chromatographica. 2009;21:71–82.
   Web of Science ®Google Scholar
• Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625–637.
   PubMed Web of Science ®Google Scholar
• Jaafar-Maalej C, Elaissari A, Fessi H. Lipid-based carriers: manufacturing and applications for pulmonary route. Expert Opin Drug Deliv. 2012;9:1111–1127.
   PubMed Web of Science ®Google Scholar
• Chung NS, Wasan KM. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake. Adv Drug Deliv Rev. 2004;56:1315–1334.
   PubMed Web of Science ®Google Scholar
• Lu X, Jin X, Huang Y, et al. Construction of a novel liver-targeting fusion interferon by incorporation of a plasmodium region I-plus peptide. Biomed Res Int. 2014;2014:1–13.
   Google Scholar
• Kader A, Davis PJ, Kara M, et al. Drug targeting using low density lipoprotein (LDL): physicochemical factors affecting drug loading into LDL particles. J Control Release. 1998;55:231–243.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Bhandari R, Bhandari S, et al. Potential of solid lipid nanoparticles in brain targeting. J Control Release. 2008;127:97–109.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56:1257–1272.
   PubMed Web of Science ®Google Scholar
• Blasi P, Giovagnoli S, Schoubben A, et al. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007;59:454–477.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh Kamal S, Sharma A, et al. Formulation and In-Vitro Evaluation of Solid Lipid Nanoparticles Containing Levosulpiride. Open Nanomed J. 2017;04:17–29.
   Google Scholar
• Vonarbourg A, Passirani C, Saulnier P, et al. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res. 2006;78:620–628.
   Google Scholar
• Allard E, Hindré F, Passirani C, et al. (188) Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas. Eur J Nucl Med Mol Imaging. 2018;35:1838–1846.
   Google Scholar
• Paul S, Nahire R, Mallik S, et al. Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery. Comput Mech. 2014;53:413–435.
   PubMed Web of Science ®Google Scholar
• Ferrari ME, Rusalov D, Enas J, et al. Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes. Nucleic Acids Res. 2002;30:1808–1816.
   PubMed Web of Science ®Google Scholar
• De Leeuw J, De Vijlder HC, Bjerring P, et al. Liposomes in dermatology today. J Eur Acad Dermatol Venereol. 2009;23:505–516.
   PubMed Web of Science ®Google Scholar
• Shende PK, Bakal RL, Gaud RS, et al. Modulation of serratiopeptidase transdermal patch by lipid-based transfersomes. J Adhes Sci Technol. 2015;29:2622–2633.
   Web of Science ®Google Scholar
• Jain N, Dubey V, Mishra DJN. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm. 2018;67:14–15.
   Google Scholar
• Vance JE. Show more GT. Cell biology of lipids formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1831:1–3.
   Google Scholar
• Wang X, Sp D, Zhang W, et al. Signaling functions of phosphatidic acid. Prog Lipid Res. 2018;45:16574237.
   Google Scholar
• Jie MSFLK, Pasha MK, Syed-Rahmatullah MSK. Fatty acids, fatty acid analogues and their derivatives. Nat Prod Rep. 1997;14:163.
   Web of Science ®Google Scholar
• Lin Y, Bogdanov M, Lu S, et al. The phospholipid-repair system LplT/Aas in Gram-negative bacteria protects the bacterial membrane envelope from host phospholipase A2 attack. J Biol Chem. 2018;293:3386–3398.
   PubMed Web of Science ®Google Scholar
• Vance JE. Historical perspective: phosphatidylserine and phosphatidylethanolamine from the 1800s to the present. J Lipid Res. 2018;59:923–944.
   PubMed Web of Science ®Google Scholar
• Enshaeieh M, Nahvi I, Madani M. Improving microbial oil production with standard and native oleaginous yeasts by using Taguchi design. Int J Environ Sci Technol. 2014;11:597–604.
   Web of Science ®Google Scholar
• Ortiz A, Killian JA, Verkleij AJ, et al. Membrane fusion and the lamellar-to-inverted-hexagonal phase transition in cardiolipin vesicle systems induced by divalent cations. Biophys J. 2018;3495:1–19.
   Google Scholar
• Talke S, Salunkhe KS, Chavan MJ, et al. A Review on nanocochleates novel approach for drug delivery. World J Pharm Pharm Sci. 2018;7:284–294.
   Google Scholar
• Akbarzadeh A, Rezaei-sadabady R, Davaran S, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:1.
   PubMed Web of Science ®Google Scholar
• Chanturiya A, Leikina E, Zimmerberg J, et al. Short-chain alcohols promote an early stage of membrane hemifusion. Biophys J. 1999;77:2035–2045..
   Google Scholar
• Markowitz D, Ha G, Ruggieri R, et al. Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism. Onco Targets Ther. 2017;10:5633–5642.
   PubMed Web of Science ®Google Scholar
• Bothiraja C, Yojana BD, Pawar AP, et al. Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study. Expert Opin Drug Deliv. 2014;11:17–29.
   PubMed Web of Science ®Google Scholar
• Loose DS, Kan PB, Hirst MA, et al. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest. 1983;71:1495–1499.
   PubMed Web of Science ®Google Scholar
• Landge A, Pawar A, Shaikh K. Investigation of cochleates as carriers for topical drug delivery. Int J Pharm Pharm Sci. 2013;5:314–320.
   Google Scholar
• Mesa-Arango AC, Scorzoni L, Zaragoza O. It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug. Front Microbiol. 2012;3:1–19.
   PubMedGoogle Scholar
• Delmas G, Park S, Chen ZW, et al. Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis. Antimicrob Agents Chemother. 2002;46:2704–2707.
   PubMed Web of Science ®Google Scholar
• Bharadwaj R, Yu H. The spindle checkpoint, aneuploidy, and cancer. Oncogene. 2004;23:2016–2027.
   PubMed Web of Science ®Google Scholar
• Joshi T, Pierroz V, Mari C, et al. A bis(dipyridophenazine)(2-(2-pyridyl)pyrimidine-4-carboxylic acid)ruthenium(II) complex with anticancer action upon photodeprotection. Angew Chem Int Ed. 2014;53:2960–2963.
   PubMed Web of Science ®Google Scholar
• Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727–737.
   PubMed Web of Science ®Google Scholar
• Başaran Mutlu Ağardan N, Değim Z, Yılmaz Ş, et al. The effectiveness of raloxifene-loaded liposomes and cochleates in breast cancer therapy. AAPS PharmSciTech. 2016;17:968–977.
   Google Scholar
• Sankar VR, Reddy YD. Nanocochleate – a new approach in lipid drug delivery. Asian J Pharm. 2010;2:2–5.
   Google Scholar
• Nagarsekar K, Zma J. Recent advances and developments in cochleate technology. Nanomed Nanotechnol. 2017;2:000119.
   Google Scholar
• Feller SE, Brown CA, Nizza DT, et al. Nuclear overhauser enhancement spectroscopy cross-relaxation rates and ethanol distribution across membranes. Biophysics J. 2018;82:3–4.
   Google Scholar
• Patra M, Salonen E, Terama E, et al. Under the influence of alcohol: the effect of ethanol and methanol on lipid bilayers. Biophys J. 2006;90:1121–1135.
   PubMed Web of Science ®Google Scholar
• Ó’Fágáin C. Lyophilization of proteins. In: Cutler P, editor. Protein purification protocols. Totowa (NJ): Humana Press. 2018. p. 8–11.
   Google Scholar
• Puri A, Paternostre M, Blumenthal R. Lipids in viral fusion. Chem Phys Lipids 2018;116:1–7.
   Google Scholar
• Lee J, Kim J, Jeong M, et al. Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration partners. Nano Lett. 2015;15:2938–2944.
   Google Scholar
• Livne L, Rf E, Rm E, et al. OAK-based cochleates as a novel approach to overcome multidrug resistance in bacteria. Faseb J. 2018;24:20720156.
   Google Scholar
• Segarra I, Movshin DA, Zarif L. Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid ‐ based delivery system. J Pharm Sci. 2002;91:1827–1837.
   Web of Science ®Google Scholar
• Wilcock BC, Endo MM, Uno BE, et al. C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells. J Am Chem Soc. 2013;135:8488–8491.
   PubMed Web of Science ®Google Scholar
• Santangelo R, Paderu P, Delmas G, et al. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob Agents Chemother. 2000;44:2356–2360.
   PubMed Web of Science ®Google Scholar
• Neumann A, Baginski M, Czub J. How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets. J Am Chem Soc. 2010;132:18266–18272.
   PubMed Web of Science ®Google Scholar
• Santangelo R, Paderu P, Delmas G, et al. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob Agents Chemother. 2000;44:2356–2360.
   PubMed Web of Science ®Google Scholar
• Hsu LW, Ho YC, Chuang EY, et al. Effects of pH on molecular mechanisms of chitosan-integrin interactions and resulting tight-junction disruptions. Biomaterials. 2013;34:784–793.
   PubMed Web of Science ®Google Scholar
• Rose W, Fernández F, Chitosan FM, et al. Chitosan in non-viral gene delivery: role of structure, characterization methods, and insights in cancer and rare diseases therapy Metadata. White Rose Research Online. 2018;502:1–4.
   Google Scholar
• Wang Y, El-Deen AG, Li P, et al. High-performance capacitive deionization disinfection of water with graphene oxide-graft-quaternized chitosan nanohybrid electrode coating. ACS Nano. 2015;9:10142–10157.
   Web of Science ®Google Scholar
• Liu M, Zhong X, Yang Z. Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A. Sci Rep. 2017;7:1–10.
   PubMed Web of Science ®Google Scholar
• Zarif L, Graybill JR, Perlin D, et al. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrob Agents Chemother. 2000;44:1463–1469.
   PubMed Web of Science ®Google Scholar
• Chaudhary VB, Pharmacy SS. Cyclodextrin inclusion complex to enhance solubility of poorly water soluble drugs: a review. Int J Pharm Sci Res. 2013;4:68–76.
   Google Scholar
• Lee DW, Lim C, Israelachvili JN, et al. Strong adhesion and cohesion of chitosan in aqueous solutions. Langmuir. 2013;29:14222–14229.
   PubMed Web of Science ®Google Scholar
• Lim C, Lee DW, Israelachvili JN, et al. Contact time- and pH-dependent adhesion and cohesion of low molecular weight chitosan coated surfaces. Carbohydr Polym. 2015;117:887–894.
   PubMed Web of Science ®Google Scholar
• Adamcewicz M, Bearelly D, Porat G, et al. Mechanism of action and toxicities of purgatives used for colonoscopy preparation. Expert Opin Drug Metab Toxicol. 2011;7:89–101.
   PubMed Web of Science ®Google Scholar
• Dluhy R, Cameron DG, Mantsch HH, et al. Fourier transform infrared spectroscopic studies of the effect of calcium ions on phosphatidylserine. Biochemistry. 1983;22:6318–6325.
   Web of Science ®Google Scholar
• Wilschut J, Duezguenes N, Papahadjopoulos D. Aggregation and fusion of phosphatidylserine vesicles and the role of bilayer curvature. Biochemistry. 2018;19:15–17.
   PubMedGoogle Scholar
• Wilschut J, Duzgunes N, Hoekstra D, et al. Modulation of membrane fusion by membrane fluidity: temperature dependence of divalent cation induced fusion of phosphatidylserine vesicles. Biochemistry. 1985;24:8–14.
   Web of Science ®Google Scholar
• Silvander M, Ringstad L, Ghadially R, et al. A new water-based topical carrier with polar skin-lipids. Lipids Health Dis. 2006;5:1–2.
   PubMed Web of Science ®Google Scholar
• Strauss M, Levy HC, Bostina M, et al. RNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectors. J Virol. 2013;87:3903–3914.
   PubMed Web of Science ®Google Scholar
• Lee S, Nguyen MT. Recent advances of vaccine adjuvants for infectious diseases. Immune Netw. 2015;15:51–57.
   PubMed Web of Science ®Google Scholar
• Ichihashi T, Satoh T, Sugimoto C, et al. Emulsified phosphatidylserine, simple and e ective peptide carrier for induction of potent epitope-specific T cell responses. Plos One. 2013;8:e60068.
   Google Scholar
• Billa AR, Guccione C, Isacchi B, et al. Essential oils loaded in nanosystems: a developing strategy for a successful therapeutic approach. Evid Based Complement Alternat Med. 2014;2014:651593.
   Web of Science ®Google Scholar
• Tamargo B, Monzote L, Piñón A, et al. In vitro and in vivo evaluation of essential oil from Artemisia absinthium L. formulated in nanocochleates against cutaneous leishmaniasis. Medicines. 2018;4:1–12.
   Google Scholar
• Pawar A, Singh S, Rajalakshmi S, et al. Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting. Artif Cells Nanomed Biotechnol. 2018;46:347–361.
   Web of Science ®Google Scholar
• Kosloski MP, Peng A, Varma PR, et al. Immunogenicity and pharmacokinetic studies of recombinant Factor VIII containing lipid cochleates. Drug Deliv. 2011;18:246–254.
   PubMed Web of Science ®Google Scholar